» Articles » PMID: 25349945

Incidence and Outcomes of Pregnancy-associated Melanoma in New South Wales 1994-2008

Overview
Date 2014 Oct 29
PMID 25349945
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is controversy about the interaction between melanoma and pregnancy. There is a lack of Australian data on pregnancy outcomes associated with melanoma in pregnancy, despite Australia having the highest incidence of melanoma in the world.

Aims: Describe trends, maternal characteristics and pregnancy outcomes associated with pregnancy-associated melanoma in New South Wales.

Materials And Methods: Population-based cohort study of all births (n = 1 309 501) of at least 20-week gestation or 400 g birthweight in New South Wales, 1994-2008. Logistic regression was used to analyse the association between melanoma in pregnancy and adverse birth outcomes.

Results: 577 pregnancy-associated melanomas were identified, including 195 diagnosed during pregnancy and 382 diagnosed within 12 months postpartum. The crude incidence of pregnancy-associated melanoma increased from 37.1 per 100 000 maternities in 1994 to 51.84 per 100 000 maternities in 2008. Adjusting for maternal age accounted for the trend in pregnancy-associated melanoma. Melanomas diagnosed in pregnancy were thicker (median = 0.75 mm) than melanomas diagnosed postpartum (median = 0.60 mm) (P = 0.002). Pregnancy-associated melanoma was associated with the increased risk of large-for-gestational-age infant but not preterm birth, planned birth, caesarean section or stillbirth. Parity was inversely associated with pregnancy-associated melanoma, as women with three or more previous pregnancies had 0.59 times the odds of pregnancy-associated melanoma compared to nulliparous women (95% CI 0.42-0.84, P = 0.003).

Conclusions: The incidence of pregnancy-associated melanoma has increased with increasing maternal age. The observation of thicker melanomas in pregnancy and increased risk of large-for-gestational-age infants may suggest a role for growth-related pregnancy factors in pregnancy-associated melanoma.

Citing Articles

Melanoma in Pregnancy-Diagnosis, Treatment, and Consequences for Fetal Development and the Maintenance of Pregnancy.

Pelczar P, Kosteczko P, Wieczorek E, Kwiecinski M, Kozlowska A, Gil-Kulik P Cancers (Basel). 2024; 16(12).

PMID: 38927879 PMC: 11202133. DOI: 10.3390/cancers16122173.


Pregnancy-Associated Cancer: A Systematic Review and Meta-Analysis.

Walters B, Midwinter I, Chew-Graham C, Jordan K, Sharma G, Chappell L Mayo Clin Proc Innov Qual Outcomes. 2024; 8(2):188-199.

PMID: 38524280 PMC: 10957385. DOI: 10.1016/j.mayocpiqo.2024.02.002.


Risk factors for the increasing incidence of pregnancy-associated cancer in Sweden - a population-based study.

Lundberg F, Stensheim H, Ullenhag G, Sahlgren H, Lindemann K, Fredriksson I Acta Obstet Gynecol Scand. 2023; 103(4):669-683.

PMID: 37694965 PMC: 10993331. DOI: 10.1111/aogs.14677.


Alcohol as a Non-UV Social-Environmental Risk Factor for Melanoma.

Yamauchi T, Shangraw S, Zhai Z, Ravindran Menon D, Batta N, Dellavalle R Cancers (Basel). 2022; 14(20).

PMID: 36291794 PMC: 9599745. DOI: 10.3390/cancers14205010.


ZIP9 Is a Druggable Determinant of Sex Differences in Melanoma.

Aguirre-Portoles C, Payne R, Trautz A, Foskett J, Natale C, Seykora J Cancer Res. 2021; 81(23):5991-6003.

PMID: 34706862 PMC: 8977092. DOI: 10.1158/0008-5472.CAN-21-0982.